9.61
price down icon1.33%   -0.13
after-market Dopo l'orario di chiusura: 9.61
loading
Precedente Chiudi:
$9.74
Aprire:
$9.84
Volume 24 ore:
2.29M
Relative Volume:
1.43
Capitalizzazione di mercato:
$3.02B
Reddito:
$2.68B
Utile/perdita netta:
$-184.45M
Rapporto P/E:
-14.12
EPS:
-0.6805
Flusso di cassa netto:
$229.23M
1 W Prestazione:
-2.14%
1M Prestazione:
+1.69%
6M Prestazione:
+11.48%
1 anno Prestazione:
+8.83%
Intervallo 1D:
Value
$9.57
$9.84
Intervallo di 1 settimana:
Value
$9.57
$10.34
Portata 52W:
Value
$6.685
$10.34

Amneal Pharmaceuticals Inc Stock (AMRX) Company Profile

Name
Nome
Amneal Pharmaceuticals Inc
Name
Telefono
908-947-3120
Name
Indirizzo
400 Crossing Boulevard, 3rd Floor, Bridgewater
Name
Dipendente
5,210
Name
Cinguettio
@amnealpharma
Name
Prossima data di guadagno
2025-05-02
Name
Ultimi documenti SEC
Name
AMRX's Discussions on Twitter

Confronta AMRX con altri titoli

Azioni Prezzo Cap. di mercato Reddito Reddito netto Flusso di cassa EPS
Drug Manufacturers - Specialty & Generic icon
AMRX
Amneal Pharmaceuticals Inc
9.61 3.06B 2.68B -184.45M 229.23M -0.6805
Drug Manufacturers - Specialty & Generic icon
ZTS
Zoetis Inc
146.93 65.35B 9.39B 2.62B 2.22B 5.81
Drug Manufacturers - Specialty & Generic icon
TAK
Takeda Pharmaceutical Co Adr
15.09 47.75B 29.96B 957.25M 4.77B 0.304
Drug Manufacturers - Specialty & Generic icon
HLN
Haleon Plc Adr
9.40 41.52B 14.26B 1.98B 2.47B 0.4347
Drug Manufacturers - Specialty & Generic icon
TEVA
Teva Pharmaceutical Industries Ltd Adr
18.38 21.43B 16.70B -157.13M 1.19B -0.155
Drug Manufacturers - Specialty & Generic icon
UTHR
United Therapeutics Corp
403.68 18.00B 2.99B 1.21B 1.13B 25.06

Amneal Pharmaceuticals Inc Stock (AMRX) Upgrades & Downgrades

Data Azione Analista Modifica della valutazione
2025-06-06 Iniziato Goldman Buy
2025-02-24 Aggiornamento JP Morgan Neutral → Overweight
2024-09-06 Aggiornamento JP Morgan Underweight → Neutral
2021-04-07 Ripresa RBC Capital Mkts Sector Perform
2021-03-08 Aggiornamento Goldman Sell → Buy
2020-12-14 Aggiornamento Barclays Equal Weight → Overweight
2020-12-14 Aggiornamento Guggenheim Neutral → Buy
2020-07-27 Iniziato Goldman Sell
2020-05-12 Aggiornamento Guggenheim Sell → Neutral
2019-12-12 Downgrade Raymond James Outperform → Mkt Perform
2019-11-12 Downgrade JP Morgan Neutral → Underweight
2019-11-07 Downgrade SVB Leerink Outperform → Mkt Perform
2019-07-22 Aggiornamento SVB Leerink Mkt Perform → Outperform
2019-07-11 Downgrade RBC Capital Mkts Outperform → Sector Perform
2019-07-08 Aggiornamento Piper Jaffray Neutral → Overweight
2019-06-11 Iniziato Barclays Equal Weight
2019-05-21 Aggiornamento Raymond James Mkt Perform → Strong Buy
2019-03-20 Iniziato SunTrust Buy
2019-03-08 Downgrade SVB Leerink Outperform → Mkt Perform
2018-12-14 Downgrade Morgan Stanley Overweight → Equal-Weight
2018-10-16 Downgrade SunTrust Buy → Hold
2018-08-13 Aggiornamento RBC Capital Mkts Sector Perform → Outperform
2018-07-23 Iniziato Morgan Stanley Overweight
2018-06-22 Iniziato B. Riley FBR, Inc. Buy
Mostra tutto

Amneal Pharmaceuticals Inc Borsa (AMRX) Ultime notizie

pulisher
Sep 17, 2025

Excessive Daytime Sleepiness Pipeline Insight 2025: Amneal’s FDA Approval of Sodium Oxybate Oral Solution, Novel Orexin Agonists, and Next-Generation Sleep-Wake Modulators Redefine Narcolepsy Care | D - Barchart.com

Sep 17, 2025
pulisher
Sep 17, 2025

Amneal Pharmaceuticals, Inc. (NASDAQ:AMRX) Given Average Recommendation of "Buy" by Analysts - MarketBeat

Sep 17, 2025
pulisher
Sep 17, 2025

JPMorgan Chase & Co. Boosts Amneal Pharmaceuticals (NASDAQ:AMRX) Price Target to $14.00 - MarketBeat

Sep 17, 2025
pulisher
Sep 17, 2025

Jones Financial Companies Lllp Takes $1.73 Million Position in Amneal Pharmaceuticals, Inc. $AMRX - MarketBeat

Sep 17, 2025
pulisher
Sep 17, 2025

Caxton Associates LLP Buys New Stake in Amneal Pharmaceuticals, Inc. $AMRX - MarketBeat

Sep 17, 2025
pulisher
Sep 17, 2025

Excessive Daytime Sleepiness Pipeline Insight 2025: Amneal's - openPR.com

Sep 17, 2025
pulisher
Sep 17, 2025

Woodline Partners LP Has $12.60 Million Stock Position in Amneal Pharmaceuticals, Inc. $AMRX - MarketBeat

Sep 17, 2025
pulisher
Sep 16, 2025

Is Amneal Pharmaceuticals Inc in a long term uptrend2025 Year in Review & Stepwise Entry and Exit Trade Signals - خودرو بانک

Sep 16, 2025
pulisher
Sep 16, 2025

AQR Capital Management LLC Buys 408,677 Shares of Amneal Pharmaceuticals, Inc. $AMRX - MarketBeat

Sep 16, 2025
pulisher
Sep 16, 2025

Acadian Asset Management LLC Has $21.76 Million Stock Holdings in Amneal Pharmaceuticals, Inc. $AMRX - MarketBeat

Sep 16, 2025
pulisher
Sep 16, 2025

Aug Rallies: Can Amneal Pharmaceuticals Inc continue delivering strong returns2025 Momentum Check & Target Return Focused Picks - خودرو بانک

Sep 16, 2025
pulisher
Sep 16, 2025

Analyst Downgrade: What are the future prospects of Amneal Pharmaceuticals Inc2025 Key Highlights & Weekly High Momentum Picks - خودرو بانک

Sep 16, 2025
pulisher
Sep 16, 2025

Aug Big Picture: Does Amneal Pharmaceuticals Inc. have pricing powerGap Up & Weekly Top Performers Watchlists - خودرو بانک

Sep 16, 2025
pulisher
Sep 16, 2025

Goldman Sachs Group Inc. Has $7.85 Million Holdings in AMNEAL PHARMACEUTICALS, INC. $AMRX - MarketBeat

Sep 16, 2025
pulisher
Sep 15, 2025

Aug Final Week: Is Amneal Pharmaceuticals Inc stock undervalued right nowQuarterly Profit Summary & Daily Growth Stock Investment Tips - خودرو بانک

Sep 15, 2025
pulisher
Sep 15, 2025

Nasdaq Moves: Is Amneal Pharmaceuticals Inc forming a double bottomQuarterly Trade Report & Long-Term Capital Growth Strategies - خودرو بانک

Sep 15, 2025
pulisher
Sep 15, 2025

Amneal secures FDA approval for sodium oxybate solution - World Pharmaceutical Frontiers

Sep 15, 2025
pulisher
Sep 15, 2025

Aug Outlook: Can Amneal Pharmaceuticals Inc continue delivering strong returnsWeekly Profit Recap & Consistent Profit Alerts - خودرو بانک

Sep 15, 2025
pulisher
Sep 15, 2025

Portfolio Update: Can Amneal Pharmaceuticals Inc continue delivering strong returnsEarnings Overview Summary & Risk Controlled Swing Alerts - خودرو بانک

Sep 15, 2025
pulisher
Sep 13, 2025

Amneal Pharmaceuticals (NASDAQ:AMRX) Hits New 52-Week HighShould You Buy? - MarketBeat

Sep 13, 2025
pulisher
Sep 12, 2025

Amneal receives FDA approval of treatment for narcoleptic sufferers - ROI-NJ

Sep 12, 2025
pulisher
Sep 12, 2025

Ophthalmic Packaging Market Worth USD 23.65 Billion by 2034 | Towards Packaging - GlobeNewswire Inc.

Sep 12, 2025
pulisher
Sep 12, 2025

Ieq Capital LLC Takes $288,000 Position in AMNEAL PHARMACEUTICALS, INC. $AMRX - MarketBeat

Sep 12, 2025
pulisher
Sep 11, 2025

Why Amneal (AMRX) Stock Is Up Today - Yahoo Finance

Sep 11, 2025
pulisher
Sep 11, 2025

Amneal wins FDA nod for generic targeting Jazz Pharma’s Xyrem - Seeking Alpha

Sep 11, 2025
pulisher
Sep 11, 2025

Amneal Pharmaceuticals Wins US FDA Approval for Generic Version of Narcolepsy Drug Xyrem - MarketScreener

Sep 11, 2025
pulisher
Sep 11, 2025

Amneal receives US FDA approval of Sodium Oxybate Oral Solution - MarketScreener

Sep 11, 2025
pulisher
Sep 11, 2025

Amneal Receives U.S. FDA Approval of Sodium Oxybate Oral Solution - GlobeNewswire

Sep 11, 2025
pulisher
Sep 11, 2025

150,000 Narcolepsy Patients Get New Option: Amneal's FDA-Approved Generic Breaks Single-Maker Market - Stock Titan

Sep 11, 2025
pulisher
Sep 11, 2025

Amneal Pharmaceuticals: A Large, Diversified Clinical Portfolio That Keeps Growing (AMRX) - Seeking Alpha

Sep 11, 2025
pulisher
Sep 10, 2025

Amneal Pharmaceuticals, Inc. $AMRX Shares Bought by Raymond James Financial Inc. - MarketBeat

Sep 10, 2025
pulisher
Sep 09, 2025

Northern Trust Corp Reduces Position in AMNEAL PHARMACEUTICALS, INC. $AMRX - MarketBeat

Sep 09, 2025
pulisher
Sep 09, 2025

684,116 Shares in AMNEAL PHARMACEUTICALS, INC. $AMRX Bought by Cubist Systematic Strategies LLC - MarketBeat

Sep 09, 2025
pulisher
Sep 08, 2025

Anti-Parkinson's Drugs Global Markets to 2030 with AbbVie, Amneal Pharmaceuticals, Acadia Pharmaceut - PharmiWeb.com

Sep 08, 2025
pulisher
Sep 08, 2025

Anti-Parkinson's Drugs Global Markets to 2030 with AbbVie, Amneal Pharmaceuticals, Acadia Pharmaceuticals, Supernus Pharmaceuticals and Teva Pharmaceutical DominatingResearchAndMarkets.com - Business Wire

Sep 08, 2025
pulisher
Sep 08, 2025

Amneal Pharmaceuticals stock hits 52-week high at $9.79 By Investing.com - Investing.com Nigeria

Sep 08, 2025
pulisher
Sep 08, 2025

Amneal Pharmaceuticals stock hits 52-week high at $9.79 - Investing.com

Sep 08, 2025
pulisher
Sep 08, 2025

Is Amneal Pharmaceuticals Inc. a strong growth stockJuly 2025 Analyst Calls & Community Shared Stock Ideas - beatles.ru

Sep 08, 2025
pulisher
Sep 08, 2025

AMNEAL PHARMACEUTICALS, INC. $AMRX Shares Bought by Dark Forest Capital Management LP - MarketBeat

Sep 08, 2025
pulisher
Sep 07, 2025

Is Amneal Pharmaceuticals Inc.’s ROE strong enough2025 Analyst Calls & Free Real-Time Volume Trigger Notifications - beatles.ru

Sep 07, 2025
pulisher
Sep 06, 2025

Should you wait for a breakout in Amneal Pharmaceuticals Inc.Bear Alert & Fast Moving Stock Trade Plans - Newser

Sep 06, 2025
pulisher
Sep 06, 2025

Can machine learning forecast Amneal Pharmaceuticals Inc. recoveryPortfolio Value Summary & Stock Portfolio Risk Management - Newser

Sep 06, 2025
pulisher
Sep 06, 2025

Amneal Pharmaceuticals, Inc. $AMRX Shares Bought by Nantahala Capital Management LLC - MarketBeat

Sep 06, 2025
pulisher
Sep 06, 2025

FDA Warns Amneal Pharmaceuticals Over Use of Contaminated IV Bags in Sterile Injectable Drug Production - geneonline.com

Sep 06, 2025
pulisher
Sep 06, 2025

Amneal gets FDA nod for generic version of Risperdal Consta - MSN

Sep 06, 2025
pulisher
Sep 06, 2025

Does Amneal Pharmaceuticals Inc. have pricing powerDollar Strength & Weekly Stock Breakout Alerts - خودرو بانک

Sep 06, 2025
pulisher
Sep 06, 2025

Trexquant Investment LP Acquires 167,631 Shares of AMNEAL PHARMACEUTICALS, INC. $AMRX - MarketBeat

Sep 06, 2025
pulisher
Sep 05, 2025

Should you avoid Amneal Pharmaceuticals Inc. stock right nowJuly 2025 Action & Low Risk Profit Maximizing Plans - خودرو بانک

Sep 05, 2025
pulisher
Sep 05, 2025

Using R and stats models for Amneal Pharmaceuticals Inc. forecastingEarnings Risk Report & Advanced Technical Signal Analysis - Newser

Sep 05, 2025
pulisher
Sep 05, 2025

What is the Moat Score of Amneal Pharmaceuticals Inc.2025 Biggest Moves & Reliable Entry Point Alerts - خودرو بانک

Sep 05, 2025
pulisher
Sep 05, 2025

Why Amneal Pharmaceuticals Inc. is moving todayGap Down & Smart Money Movement Alerts - Newser

Sep 05, 2025

Amneal Pharmaceuticals Inc Azioni (AMRX) Dati Finanziari

Reddito

loading

Reddito netto

loading

Flusso di cassa

loading

EPS

loading
$27.87
price up icon 1.75%
$18.43
price down icon 1.07%
$9.62
price up icon 0.63%
drug_manufacturers_specialty_generic RDY
$14.86
price up icon 0.88%
$142.73
price up icon 1.30%
$403.68
price up icon 1.43%
Capitalizzazione:     |  Volume (24 ore):